The use of hemodynamics to predict mortality in patients undergoing primary PCI for ST-elevation myocardial infarction

References

• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American heart association. Circulation. 2017;135:e146–h^#-e603. Epub 2017 Jan 25
   Web of Science ®Google Scholar
• Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol. 1967;20:457–464.
   PubMed Web of Science ®Google Scholar
• DeGeare VS, Boura JA, Grines LL, et al. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2001;87: 1035–8
   PubMed Web of Science ®Google Scholar
• Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102: 2031–7
   PubMedGoogle Scholar
• Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163: 2345–53
   PubMedGoogle Scholar
• Gale CP, Manda SO, Batin PD, et al. Predictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) database. Heart. 2008;94:1407–1412. Epub 2007 Dec 10. doi: 10.1136/hrt.2007.127068
   PubMedGoogle Scholar
• Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol. 2004;93: 629–32. doi: 10.1016/j.amjcard.2003.11.036
   PubMed Web of Science ®Google Scholar
• Van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American heart association. Circulation. 2017;136:e232–e268. Epub 2017 Sep 18. doi: 10.1161/CIR.0000000000000525
   PubMed Web of Science ®Google Scholar
• Page DL, Caulfield JB, Kastor JA, DeSanctis, R W., Sanders, C A. Myocardial changes associated with cardiogenic shock. N Engl J Med. 1971;285(3):133–137. doi: 10.1056/NEJM197107152850301.
   PubMed Web of Science ®Google Scholar
• Reyentovich A, Barghash MH, Hochman JS. Management of refractory cardiogenic shock. Nat Rev Cardiol. 2016;13:481–492. Epub 2016 Jun 30. doi: 10.1038/nrcardio.2016.96
   PubMed Web of Science ®Google Scholar
• Aymong ED, Ramanathan K, Buller CE. Pathophysiology of cardiogenic shock complicating acute myocardial infarction. Med Clin North Am. 2007;91:701–12; xii.
   Google Scholar
• Nicholls SJ, Wang Z, Koeth R, et al. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation. 2007;116:2315–2324. Epub 2007 Oct 29. doi: 10.1161/CIRCULATIONAHA.107.693986
   PubMed Web of Science ®Google Scholar
• Menon V, Slater JN, White HD, et al. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med. 2000;108:374–380
   PubMed Web of Science ®Google Scholar
• Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation. 1995;91:1659–1668
   PubMed Web of Science ®Google Scholar
• Stebbins A, Mehta RH, Armstrong PW, L et al. A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the assessment of pexelizumab in acute myocardial infarction trial. Circ Cardiovasc Interv. 2010;3:414–422. Epub 2010 Sep 21. doi: 10.1161/CIRCINTERVENTIONS.109.925180
   PubMed Web of Science ®Google Scholar
• Bagai A, Armstrong PW, Stebbins A, et al. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: findings from the assessment of pexelizumab in acute myocardial infarction study. Am Heart J. 2013;166:913–919. Epub 2013 Sep 24. doi: 10.1016/j.ahj.2013.08.006
   PubMed Web of Science ®Google Scholar
• Planer D, Mehran R, Witzenbichler B, et al. Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2011;108: 1068–74. Epub 2011 Jul 27. doi: 10.1016/j.amjcard.2011.06.007
   PubMed Web of Science ®Google Scholar
• Sola M, Venkatesh K, Caughey M, et al. Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2017;17:26963.
   Google Scholar
• Tesak M, Kala P, Jarkovsky J, et al. The value of novel invasive hemodynamic parameters added to the TIMI risk score for short-term prognosis assessment in patients with ST segment elevation myocardial infarction. International Journal of Cardiology 2016;214:235–240
   PubMed Web of Science ®Google Scholar
• Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med. 1976;295:1404–1413. doi: 10.1056/NEJM197612162952505
   PubMed Web of Science ®Google Scholar
• Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44:340–348.
   PubMed Web of Science ®Google Scholar
• Hasdai D, Holmes DR Jr., Califf RM, et al. Cardiogenic shock complicating acute myocardial infarction: predictors of death. Am Heart J. 1999;138:21–31.
   PubMedGoogle Scholar
• Korabathina R, Heffernan KS, Paruchuri V, et al. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Catheter Cardiovasc Interv. 2012;80:593–600. Epub 2012 Jan 10
   PubMed Web of Science ®Google Scholar
• Lopez-Sendon J, Coma-Canella I, Gamallo C. Sensitivity and specificity of hemodynamic criteria in the diagnosis of acute right ventricular infarction. Circulation 1981;64:515–525.
   PubMed Web of Science ®Google Scholar
• Reinstadler SJ, Fuernau G, Eitel C, et al. Shock index as a predictor of myocardial damage and clinical outcome in ST-elevation myocardial infarction. Circulation Journal 2016;80:924–930.
   PubMed Web of Science ®Google Scholar
• Shangguan Q, Xu JS, Su H, et al. Modified shock index is a predictor for 7-day outcomes in patients with STEMI. Am J Emerg Med. 2015;33:1072–1075. Epub 2015 May 1. doi: 10.1016/j.ajem.2015.04.066.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382:1638–1645. Epub 2013 Sep 3. doi: 10.1016/S0140-6736(13)61783-3
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287–1296. Epub 2012 Aug 26. doi: 10.1056/NEJMoa1208410
   PubMed Web of Science ®Google Scholar
• Ahmad Y, Sen S, Shun-Shin MJ, et al. Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis. JAMA Intern Med. 2015;175: 931–939. doi: 10.1001/jamainternmed.2015.0569
   PubMed Web of Science ®Google Scholar
• Unverzagt S, Buerke M, de Waha A, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2015;CD007398. DOI:10.1002/14651858.CD007398.pub3.
   PubMed Web of Science ®Google Scholar
• Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52: 1584–8. doi: 10.1016/j.jacc.2008.05.065
   Web of Science ®Google Scholar
• Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69:278–287. Epub 2016 Oct 31
   PubMed Web of Science ®Google Scholar
• Parissis, H., Haemodynamic effects of the use of the intraaortic balloon pump. Hellenic J Cardiol., 2007. 48(6):346–51.
   PubMedGoogle Scholar
• Werdan, K., et al., Mechanical circulatory support in cardiogenic shock. Eur Heart J., 2014. 35(3):156–67. Epub 2013 Sep 7. doi: 10.1093/eurheartj/eht248
   PubMed Web of Science ®Google Scholar
• Prondzinsky, R., et al., Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock., 2012. 37(4):378–84. doi: 10.1097/SHK.0b013e31824a67af.
   PubMed Web of Science ®Google Scholar
• Auffret, V., et al., Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score. Eur Heart J., 2018. 39(22):2090–2102.
   PubMed Web of Science ®Google Scholar